Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study
Language English Country Great Britain, England Media print
Document type Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
Grant support
5-100
Russian Academic Excellence Project
PubMed
33523099
DOI
10.1093/rheumatology/keab071
PII: 6125371
Knihovny.cz E-resources
- Keywords
- ANCA-associated vasculitis, risk factors, venous thromboembolic events,
- MeSH
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis complications immunology MeSH
- Skin Diseases epidemiology immunology MeSH
- Skin immunology MeSH
- Kidney immunology MeSH
- Middle Aged MeSH
- Humans MeSH
- Kidney Diseases epidemiology immunology MeSH
- Odds Ratio MeSH
- Lung immunology MeSH
- Lung Diseases epidemiology immunology MeSH
- Regression Analysis MeSH
- Retrospective Studies MeSH
- Heart Disease Risk Factors MeSH
- Aged MeSH
- Venous Thromboembolism epidemiology immunology MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Europe epidemiology MeSH
- North America epidemiology MeSH
OBJECTIVE: To investigate the occurrence of venous thromboembolic events (VTE) in a large cohort of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) across the European Union, Turkey, Russia, UK and North America. METHODS: Patients with a definite diagnosis of AAV who were followed for at least 3 months and had sufficient documentation were included. Data on VTE, including either deep vein thrombosis or pulmonary embolism, were collected retrospectively from tertiary vasculitis centres. Univariate and multivariate regression models were used to estimate odds ratios (ORs) and 95% CIs. RESULTS: Over a median follow-up of 63 (interquartile range: 29, 101) months, VTE occurred in 278 (9.7%) of 2869 AAV patients with a similar frequency across different countries (from 6.3% to 13.7%), and AAV subtype [granulomatosis with polyangiitis: 9.8% (95% CI: 8.3, 11.6%); microscopic polyangiitis: 9.6% (95% CI: 7.9, 11.4%); and eosinophilic granulomatosis with polyangiitis: 9.8% (95% CI: 7.0, 13.3%)]. Most VTE (65.6%) were reported in the first-year post-diagnosis. Multiple factor logistic regression analysis adjusted for sex and age showed that skin (OR 1.71, 95% CI: 1.01, 2.92), pulmonary (OR 1.78, 95% CI: 1.04, 3.14) and kidney [eGFR 15-60 ml/min/1.73 m2, OR 2.86 (95% CI: 1.27, 6.47); eGFR <15 ml/min/1.73 m2, OR 6.71 (95% CI: 2.94, 15.33)] involvement were independent variables associated with a higher occurrence of VTE. CONCLUSION: Two-thirds of VTE occurred during the initial phase of active disease. We confirmed previous findings from smaller studies that a decrease in kidney function, skin involvement and pulmonary disease are independently associated with VTE.
Beaumont Hospital Dublin Ireland
Department of Clinical Sciences Lund Nephrology Lund University Lund Sweden
Department of Internal Medicine 4 Medical University Innsbruck Innsbruck Austria
Department of Medicine Centre for Inflammatory Disease Imperial College London London UK
Department of Medicine University of Cambridge Cambridge UK
Department of Nephrology and Dialysis Dubrava University Hospital Zagreb Croatia
Department of Pathology Leiden University Medical Center Leiden The Netherlands
Department of Rheumatology Skåne University Hospital Lund Sweden
Division of Nephrology Department of Medicine Johns Hopkins University Baltimore MD USA
Faculty of Medicine Lomonosov Moscow State University Moscow Russia
Irish Centre for Vascular Biology Tallaght University Hospital
Tareev Clinic of Internal Diseases Sechenov 1st Moscow State Medical University
Trinity Health Kidney Centre Trinity Translational Medicine Institute
Vasculitis and Lupus Clinic Addenbrooke's Hospital Cambridge University Hospitals Cambridge UK
References provided by Crossref.org